Ibogaine is from the root bark of the Central West-African plant Tabernanthe Iboga, used traditionally in rites of passage and healing rituals. Ibogaine is the most researched Iboga-alkaloid; its alkaloids also have tremendous therapeutic properties.
Detoxification from opioids with a single large dose of Ibogaine has been consistently observed in humans and corresponds to a large body of animal work. Treatment with Ibogaine is followed by a total elimination of withdrawals and craving for multiple substances including opiates, cocaine, stimulants, methamphetamine, alcohol, benzodiazepines and nicotine. The Iboga experience facilitates a profound revision of one’s personal history and life situation and adjustment of one’s behavior and role in the family and society. New Zealand was the first country in the world to accept Ibogaine as a prescription medication in 2009 followed by Israel.